Advertisement

Gastric Bypass pp 411-420 | Cite as

Gastric Bypass in Patients with Metabolic Syndrome

  • Mariano Palermo
  • Maria del Pilar Quevedo
  • Edgardo Serra
  • Marianela Aguirre Ackermann
Chapter
  • 33 Downloads

Abstract

Metabolic surgery was defined by Varco and Buchwald as “the operative manipulation of a normal organ or organ system to achieve a biological result for a potential health gain.” Type 2 diabetes (T2DM) is one of the largest health emergencies of the twenty-first century. Hyperglycemia defines diabetes, and glycemic control is fundamental to diabetes management. Several trials have provided evidence that appropriate glycemic control could lead to a significant reduction in the risk of long-term diabetic complications. Bariatric surgery was initially developed as a tool for weight reduction in severely obese patients. Gastrointestinal operations have demonstrated, especially those that involve food rerouting through the gastrointestinal tract that are safe and provide better outcomes for weight loss and improvement in glucose metabolism in obese patients with type 2 diabetes (T2DM) in comparison to conventional strategies. Bariatric/metabolic procedures have even shown to cause remission of the disease as well as demonstrated extraordinary benefits on lipids and blood pressure control, suggesting good long-term effects on cardiovascular risk profile and mortality. RYGB technique was the first technique that proved its effectiveness in remission of T2DM in morbidly obese patients. Laparoscopic RYGB is the most accepted and effective procedure; it is also the safest and has the best long-term T2DM remission rates compared with other restrictive techniques. These characteristics postulate laparoscopic RYGB as the gold standard.

Keywords

Gastric bypass Metabolic syndrome Hyperglycemia Bariatric surgery Metabolic surgery T2DM Remission Laparoscopic surgery Gold standard Follow-up 

References

  1. 1.
    Buchwald H. Metabolic surgery. In: Lucchese M, Scopinaro N, editors. Bariatric and metabolic mini-invasive surgery. New York: Springer; 1978.Google Scholar
  2. 2.
    IDF Atlas 7th. Edition 2015. www.diabetesatlas.org.
  3. 3.
    Gaede P, Lund-Andersen H, Parving H-H, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358:580–91.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2016;39: 88–99(Suppl.1).Google Scholar
  5. 5.
    Stark Casagrande S, Fradkin JE, Sayad SH, Rust KF, Cowie CC. The prevalence of meeting A1c, blood pressure, and LDL goals among people with diabetes, 1998–2010. Diabetes Care. 2013;36:2271–9.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Cohen R, Caravatto PP, Petry T. Surgery for diabetes. Curr Surg Rep. 2013;1:160.CrossRefGoogle Scholar
  7. 7.
    UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk for complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRefGoogle Scholar
  8. 8.
    Ismail-Beigi F, Craven T, Banerji MA, ACCORD Trial Group, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010;376:419–30.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Patel A, Mac Mahon S, Chalmers J, ADVANCE Collaborative Group, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–72.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Duckworth W, Abraira C, Moritz T, VADT Investigators, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2008;359:1577–89.CrossRefGoogle Scholar
  11. 11.
    Sjöström L, et al. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.CrossRefGoogle Scholar
  12. 12.
    Sjostrom L, Peltonen M, Jacobson P, et al. Bariatric surgery and long term cardiovascular events. JAMA. 2012;307:56–65.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Sjostrom L, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Cohen R, Caravatto PP, Petry T. Metabolic surgery for type 2 diabetes in patients with BMI of <35 kg/m2: a surgeon’s perspective. Obes Surg. 2013;23:809–18. Comprehensive review of metabolic surgery in BMI below 35 kg/m2.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1577–85.CrossRefGoogle Scholar
  16. 16.
    Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567–76.PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Cohen R, Caravatto PP, Petry T, Cummings D. Role of metabolic surgery in less obese or non-obese subjects with type 2 diabetes: influence over cardiovascular events. Curr Atheroscler Rep. 2013;15:355.PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Cummings DE, Flum DR. Gastrointestinal surgery as a treatment for diabetes. JAMA. 2008;299:341–3.PubMedPubMedCentralGoogle Scholar
  19. 19.
    Ikkramudin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA. 2013;309:2240–9.CrossRefGoogle Scholar
  20. 20.
    Laferrere B, Texeira J, McGinty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and uncertain levels in patients with type 2 diabetes. J Clin Endocrinol Metab. 2008;93:2479–85.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239:1–11.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Savage DB, Petersen KF, Schulman GI. Disordered lipid metabolism and pathogenesis of insulin resistance. Phys Rev. 2007;87:507–20.Google Scholar
  23. 23.
    Pories WJ, Dohm LG, Mansfield CJ. Beyond the BMI: the search for better guidelines for bariatric surgery. Obesity. 2010;18:865–71.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Bojsen-Moller KN, Dirksen C, Jorgensen NB, et al. Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased post-prandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass. Diabetes. 2014;63:1725–37.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Salinari S, Bertuzzi A, Guidone C, Previti E, Rubino F, Mingrone G. Insulin sensitivity and secretion changes after gastric by pass in normotolerant and diabetic obese subjects. Ann Surg. 2013;257:462–8.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Dirksen C, Bojsten- Moller KN, Jorgensen NB, et al. Exaggerated release and preserved insulinotropic action of glucagon-like-peptide 1underlie insulin hypersecretion in glucose-tolerant individual after Roux-en Y gastric bypass. Diabetologia. 2013;56:2679–87.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Lindqvist A, Spegel P, Ekelund M, et al. Gastric by pass improves B-cell function and increases B-cell mass in a porcine model. Diabetes. 2014;63:1665–71.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Rubino F, Amiel SA. Is the gut the “sweet spot” for the treatment of diabetes ? Diabetes. 2014;63:2225–8.PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Jacob BP, Gagner M. New developments in gastric bypass procedures and physiological mechanisms. Surg Technol Int. 2003;11:119–26.PubMedPubMedCentralGoogle Scholar
  30. 30.
    Palermo M, Gimenez M, Gagner M. Laparoscopic gastrointestinal surgery. Novel techniques, extending the limits. Caracas: AMOLCA; 2015.Google Scholar
  31. 31.
    Himpens JM. The gastrojejunostomy in laparoscopic Roux-en-Y gastric bypass. Semin Laparosc Surg. 2004;11(3):171–7.Google Scholar
  32. 32.
    Cadière GB, Himpens J, Dapri G. Laparoscopic stomach bypass surgery. Chirurg. 2005;76(7):668–77.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Palermo M, Dapri G. Single port laparoscopic surgery. Medellin, Colombia: AMOLCA; 2015.Google Scholar
  34. 34.
    Collins BJ, Miyashita T, Schweitzer M, Magnuson T, Harmon JW. Gastric bypass: why Roux-en-Y? A review of experimental data. Arch Surg. 2007;142(10):1000–3; discussion 1004.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Madan AK, Harper JL, Tichansky DS. Techniques of laparoscopic gastric bypass: on-line survey of American Society for Bariatric Surgery practicing surgeons. Surg Obes Relat Dis. 2008;4(2):166–72; discussion172–3.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Franco JV, Ruiz PA, Palermo M, Gagner M. A review of studies comparing three laparoscopic procedures in bariatric surgery: sleeve gastrectomy, Roux-en-Y gastric bypass and adjustable gastric banding. Obes Surg. 2011;21(9):1458–68.CrossRefGoogle Scholar
  37. 37.
    Acquafresca P, Palermo M, Duza G, Blanco L, Serra E. Gastric Bypass versus Sleeve gastrectomy: comparison between type 2 Diabetes weight loss and complications. Review of randomized control trails. Acta Gastroenterol Latinoam. 2015;45:284–7.Google Scholar
  38. 38.
    Acquafresca PA, Palermo M, Rogula T, Duza GE, Serra E. Early complications after gastric by-pass: a literature review. Arq Bras Cir Dig. 2015;28(1):74–80.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    De Luca M, Angrisani L, Himpens J, et al. Indications for surgery for obesity and weight- related diseases: position statements from the International Federation for the Surgery of Obesity an Metabolic Disorders (IFSO). Obes Surg. 2016;26:1659–96.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Rubino R, Kaplan LM, Schauer PR, Cummings DE. The diabetes surgery summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg. 2010;251:399–405.PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Rubino F, et al. Bariatric, metabolic and diabetes surgery: what’s in a name? Ann Surg. 2012;34:1–6.Google Scholar
  42. 42.
    Rubino F, Cummings DE, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes. A joint statement by international diabetes organizations. Diabetes Care. 2016;39:861.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Carlsson LM, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367:695–704.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Alberti MM, Zimmet PZ, Del Prato S, Ji L, Sadikot SM, Amiel SA, Kaplan LM, Herman WH, Taroncher-Oldenburg G, Cummings DE. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016;39:861–77.PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Ramos AC, Silva ACS, Ramos MG, Cansaco EGC, dos Passos Galvao Neto M, de Almeida Menexes M, Galvao TD. Eduardo Lemos de Souza Bastos. ABCD Arq Bras Cir Dig. 2014;27(Suppl. 1):2–8.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Fletcher R, Deal R, Kubasiak J, Torquati A, Omotosho P. Predictors of Increased Length of Hospital Stay Following Laparoscopic Sleeve Gastrectomy from the National Surgical Quality Improvement Program. J Gastrointest Surg. 2018;22(2):274–8. https://doi.org/10.1007/s11605-017-3642-4. Epub 2017 Dec 5.PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Bussetto L, Dixon J, De Luca M, Shikora S, Pories W, Angrisani L. Bariatric surgery in class I obesity: a position statement from the International Federation For De Surgery Of Obesity And Metabolic Disorders. Obes Surg. 2014;24:487–519.CrossRefGoogle Scholar
  48. 48.
    Henry B, Estok R, Fahrbach K, Banel D, Jensen MD, Pories W, Bantle J, Sledge I. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2008;122:248–256.e5.  https://doi.org/10.1016/j.amjmed.2008.09.041.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Mariano Palermo
    • 1
  • Maria del Pilar Quevedo
    • 1
  • Edgardo Serra
    • 2
  • Marianela Aguirre Ackermann
    • 1
  1. 1.Division of Bariatric Surgery Centro CIEN – DIAGNOMEDInstitution to the University of Buenos AiresBuenos AiresArgentina
  2. 2.Division of Bariatric Surgery Centro CIEN – DIAGNOMEDAffiliated Institution to the University of Buenos Aires and DAICIM FoundationBuenos AiresArgentina

Personalised recommendations